凝血酶
肽
直接凝血酶抑制剂的发现与发展
抗凝剂
化学
凝血酶时间
凝结
对接(动物)
虚拟筛选
体内
体外
生物化学
药理学
抗凝药
药品
血瘀
凝血酶原时间
肽库
表面等离子共振
纤维蛋白原
凝血活酶
肽序列
生物活性
药物发现
作者
Yu‐Tong Hua,Ruijuan Dong,Yin Li,Zhao‐Yu‐Qing Su,Quan‐Cheng Xin,Meng Shen,Yaxiong Liu,Xiuhuan Guo,Yan Lei,Yuting Zhang,Gaimei She,Wei Peng,Ruijuan Yuan
摘要
ABSTRACT Targeting thrombin to screen safe thrombin inhibitors from natural plants and animals is a critical direction in anticoagulant drug development. This study aimed to screen thrombin inhibitors from the nonbloodsucking leech Whitmania pigra (WP) and elucidate the mechanism of anticoagulation through a “computation‐guided experimentation” strategy. A peptide library was constructed from WP hydrolysates, and virtual screening was performed using molecular docking and dynamics simulations. A novel thrombin‐targeting anticoagulant peptide PEP WP (LRELEDALEQER) was screened out from the peptide library and validated through in vitro/in vivo experiments. PEP WP significantly prolonged thrombin time (TT) and prothrombin time (PT) in a dose‐dependent manner in vitro, indicating its role in the common and extrinsic coagulation pathways. Surface plasmon resonance (SPR) analysis then confirmed strong thrombin binding ( K d = 7.242 × 10 −6 mol/L). Furthermore, PEP WP prolonged TT while reducing blood viscosity in acute blood stasis rats. Finally, structural analysis revealed that PEP WP bound to Exosite II of thrombin. Arg233 and Arg101 were the key residues for the binding. In conclusion, PEP WP exhibited good anticoagulant activity and significant application potential.
科研通智能强力驱动
Strongly Powered by AbleSci AI